Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hookipa Pharma Inc (HOOK)

Hookipa Pharma Inc (HOOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hookipa Pharma Inc 350 FIFTH AVENUE 72ND FLOOR SUITE 7240 NEW YORK NY 10118 USA

www.hookipapharma.com Employees: 87 P: 431-890-6360

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company. It is engaged in developing a class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform which is designed to reprogram the body's immune system. HOOKIPA Pharma Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 10,765
Enterprise Value, $K -29,015
Shares Outstanding, K 12,189
Annual Sales, $ 43,950 K
Annual Net Income, $ -43,500 K
Last Quarter Sales, $ 710 K
Last Quarter Net Income, $ 1,110 K
EBIT, $ -51,800 K
EBITDA, $ -49,050 K
60-Month Beta 0.91
% of Insider Shareholders 3.30%
% of Institutional Shareholders 63.88%
Float, K 11,787
% Float 96.70%
Short Interest 12
Short Float 0.10%
Short Volume Ratio 0.03

Growth:

1-Year Return -56.68%
3-Year Return -90.22%
5-Year Return -99.20%
5-Year Revenue Growth 268.09%
5-Year Earnings Growth 86.47%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.09 on 11/14/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -3.50
EPS Growth vs. Prev Qtr 122.50%
EPS Growth vs. Prev Year 108.18%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/10/24

HOOK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -113.19%
Return-on-Assets % -68.81%
Profit Margin % -98.98%
Debt/Equity 0.00
Price/Sales 0.25
Price/Cash Flow N/A
Price/Book 0.37
Book Value/Share 2.46
Interest Coverage -0.62
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar